March 24, 2024Agreement Regarding Certain Board Matters • April 26th, 2024 • Nuvation Bio Inc. • Pharmaceutical preparations
Contract Type FiledApril 26th, 2024 Company IndustryThis Agreement records certain agreements between you and Dr. David Hung (“Dr. Hung”), the record and beneficial holder of 100% of the issued and outstanding shares of Parent Class B Common Stock (the “Class B Shares”), regarding certain matters with respect to the post-Closing board of directors of Parent (the “Board”). Capitalized terms not otherwise defined herein shall bear the meaning given to them in the Merger Agreement.
March 24, 2024 Jerry Wang Princeton, NJ 08540 E-mail: jwang@anhearttherapeutics.com AnHeart Therapeutics Ltd. New York, NY 10017 Attention: Junyuan (Jerry) Wang E-mail: jwang@anhearttherapeutics.comAgreement Regarding Certain Board Matters • March 26th, 2024 • Hung David • Pharmaceutical preparations
Contract Type FiledMarch 26th, 2024 Company IndustryThis Agreement records certain agreements between you and Dr. David Hung (“Dr. Hung”), the record and beneficial holder of 100% of the issued and outstanding shares of Parent Class B Common Stock (the “Class B Shares”), regarding certain matters with respect to the post-Closing board of directors of Parent (the “Board”). Capitalized terms not otherwise defined herein shall bear the meaning given to them in the Merger Agreement.